Bucolome is a CYP2C9 inhibitor, used as an uricosuric agent or anti-inflammatory agent. References: [1]. Takahashi H, et al. Pharmacokinetic interaction between warfarin and a uricosuric agent, bucolome: application of In vitro approaches to predicting In vivo reduction of (S)-warfarin clearance. Drug Metab Dispos. 1999 Oct;27(10):1179-86.

纯度：≥98%

CAS：841-73-6